https://twitter.com/ckd_ce/status/173201663020748834913a) The other major class of drugs currently being eval'd in #IgAN is the #complement inhibitors. ✔️out 🔓https://bit.ly/46IZbRA. At #KidneyWk we saw 1st data for the C5 inhibitor #Ravulizumabin IgAN, a drug we know well in atypical #HUS & #PNH: 🔓 https://bit.ly/480jjzJ
— @CKD_ce (@ckd_ce) Dec 5, 2023
Tuesday, December 5, 2023
@ckd_ce
http://twitter.com/ckd_ce
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment